Therefore, we anticipate that the use of flies with LRRK2 mutations associated with familial PD (e.g., G2019S, BDSC#602459) might increase the success of finding an effective inhibitor of hLRRK2 for the treatment of PD. The gene discussed is LRRK2; the disease is Parkinson disease.